Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis.
Damiano MarastoniFrancesco CrescenzoAnna I PisaniCarmela ZucoGianmarco SchiaviGiulia BenedettiGiuseppe K RicciardiStefania MontemezziFrancesca B PizziniAgnese TamantiMassimiliano CalabresePublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Beyond the well-known effect on disease activity, these results provide evidence of the effect of DMF through reduced progression of focal and diffuse GM damage.